In this edition:
–  Intervention for improving acute HF outcomes
–  Dapagliflozin in HFimpEF
–  Empagliflozin in HFpEF vs. HF with midrange EF
–  Intravenous ferric derisomaltose in iron-deficient HF
–  Up-titration of guideline-directed medical therapies for acute HF
–  Associations of all-cause mortality with statin therapy in HFpEF
–  Empagliflozin improves outcomes in HFpEF irrespective of BP
–  Combining loop with thiazide diuretics for decompensated HF
–  Decongestion with acetazolamide in acute decompensated HF across LVEF spectrum
–  Ambulatory haemodynamic-guided management reduces HF hospitalisations

Download Heart_Failure_Research_Review:_Issue_74(pdf) with commentary by Prof Andrew Coats